Hyun Jung Kim, PhD
Assistant Professor, Cleveland Clinic, Current Grantee
The Kim lab emulates host-microbiome interactions that orchestrate intestinal homeostasis and disease development. They develop “Personalized Disease-on-a-Chip” models by integrating patient-derived organoids, microbiomes and immune cells.
Meghan Koch, PhD
Assistant Professor, Fred Hutchinson Cancer Research Center, Current Grantee
The Koch lab studies maternal-fetal interactions, focusing on immunity, metabolism and the microbiota. They are working to identify novel pathways through which maternal-offspring interactions regulate neonatal health.
Alison Kohan, PhD
Associate Professor, University of Pittsburgh, Former Grantee
The Kohan lab focuses on the role of lipoproteins in regulating cellular metabolism in the immune system and the intestine, and the consequences for human disease.
Daniel Kotlarz, PhD
Joint Helmholtz Young Investigator Group Leader, Helmholtz Munich and Dr. von Hauner Children's Hospital, LMU Munich; Current Grantee
The Kotlarz lab focuses on decoding genetic and immune signatures of Pediatric IBD by employing omics-based technologies and advanced preclinical models.
Adam Lacy-Hulbert, PhD
Associate Member, Benaroya Research Institute at Virginia Mason, Current Grantee
The Lacy-Hulbert lab works to understand how different aspects of the immune system cooperate to identify and combat potentially infectious organisms while preventing immune attack against innocuous microbes or the body’s own self.
Dale Lee, MD
Associate Professor, Seattle Children's Hospital, Current Grantee
Dr. Lee studies dietary therapy and the role of food additives in IBD with the goal of helping children achieve their potential and not be limited by their medical conditions.
